Rhode Island H7825 mandates the secretary of the executive office of health and human services to monitor and mandate changes to pharmacy benefit.
Rhode Island H7825 requires the secretary of the executive office of health and human services to oversee and mandate changes to the price-setting practices of pharmacy benefit managers to prohibit the spread pricing payment model. This model involves pharmacy benefit managers charging a health plan more than they reimburse the pharmacy for a prescription drug and retaining the difference. The bill aims to protect Rhode Islanders and the state Medicaid program from high prescription drug costs by ensuring greater transparency and accountability from pharmacy benefit managers.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.